Physician profile

Hafeza Shaikh

Nuclear Cardiology · Willingboro, NJ

NPI 1235320870

$16,103.43

in general payments reported to CMS, 2019-2025

44 companies · $1,942 in 2025

The $1,942 reported for 2025 was more than what 84% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).

See the full distribution for Nuclear Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,410.31
Travel and Lodging$452.28
Education$9.09

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,989.47 2019-2025 Watchman Access System, General - Therapies, Watchman Flx
Atricure, INC. $1,403.22 2022-2024
Amgen INC. $1,364.81 2019-2025 Repatha, Repatha
Abbott Laboratories $1,123.50 2019-2025 Gallant, Aveir, Assurity
Novartis Pharmaceuticals Corporation $1,050.04 2019-2025
E.R. Squibb & Sons, L.L.C. $936.81 2020-2025 Camzyos, Eliquis
Janssen Pharmaceuticals, INC $799.58 2019-2023 Xarelto
Astrazeneca Pharmaceuticals LP $798.65 2019-2025 Farxiga, Wainua
Pfizer INC. $707.27 2019-2024
Impulse Dynamics (USA) INC. $669.57 2019-2025 Optimizer, Optimizer
Boehringer Ingelheim Pharmaceuticals, INC. $613.20 2020-2025 Jardiance
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $584.25 2019-2025 Lifevest
Merck Sharp & Dohme LLC $516.72 2021-2025 Verquvo, Capvaxive
Medtronic, INC. $369.95 2021-2023 Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan
Irhythm Technologies, INC. $353.87 2019-2024 Zio Xt Patch, Zio Monitor
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Esperion Therapeutics, INC. $235.06 2020-2025 Nexletol
Lexicon Pharmaceuticals, INC. $214.58 2023-2024 Inpefa
W. L. Gore & Associates, INC. $197.77 2020-2022
Abiomed $164.35 2023-2024 Impella
Kestra Medical Technology Services, INC. $105.35 2023-2025 Assure Wcd
Bayer Healthcare Pharmaceuticals INC. $93.21 2025
Preventice Services, LLC $80.55 2020-2021
Amarin Pharma, INC. $68.49 2019-2020
Scpharmaceuticals INC. $63.96 2023-2025
Kiniksa Pharmaceuticals International, Plc $62.03 2024 Arcalyst
Medtronic Vascular, INC. $56.52 2019
Alnylam Pharmaceuticals INC. $55.75 2025 Onpattro
Edwards Lifesciences Corporation $51.36 2022-2025 Edwards Sapien 3 Ultra Transcatheter Heart Valve
Kowa Pharmaceuticals America, INC. $48.32 2019-2021
Regeneron Healthcare Solutions, INC. $43.05 2019-2023 Evkeeza
Heartflow, INC. $41.99 2024-2025
Astellas Pharma US INC $28.70 2019-2021
Novo Nordisk INC $26.83 2021
Cvrx, INC. $24.59 2025 Barostim Neo System
Glaxosmithkline, LLC. $21.62 2025 Arexvy, Shingrix
Genzyme Corporation $18.97 2023
Bridgebio Pharma, INC. $17.70 2025 Attruby
Sanofi-Aventis U.S. LLC $17.18 2022
Kiniksa Pharmaceuticals, LTD. $16.67 2023 Arcalyst
Terumo Medical Corporation $16.33 2024 Glidewire, Metacross Otw, Progreat
Chiesi USA, INC. $15.53 2019
Ionis Pharmaceuticals, INC. $13.93 2025 Tryngolza
Allergan, INC. $11.29 2019
Daiichi Sankyo INC. $10.84 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hafeza Shaikh

$16,103.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,942 reported for 2025 was more than what 84% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).

https://glasscript.com/doctor/101720/hafeza-shaikh

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.